ENTRY       D04431                      Drug
NAME        Hepatitis B immune globulin (USP);
            Hepatitis B immnoglobulin;
            Bayhep B (TN);
            Fovepta (TN)
PRODUCT     HEPAGAM B (Saol Therapeutics)
            HEPAGAM B (Saol Therapeutics)
            NABI-HB (ADMA Biologics)
REMARK      ATC code: J06BB04
            Product: D04431<US>
EFFICACY    Immunizing agent (passive), Prophylactic (hepatitis B)
  DISEASE   Hepatitis B [DS:H00412]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J06 IMMUNE SERA AND IMMUNOGLOBULINS
               J06B IMMUNOGLOBULINS
                J06BB Specific immunoglobulins
                 J06BB04 Hepatitis B immunoglobulin
                  D04431  Hepatitis B immune globulin (USP) &lt;US&gt;
            USP drug classification [BR:br08302]
             Immunological Agents
              Immunoglobulins
               Hepatitis B Immune Globulin
                D04431  Hepatitis B immune globulin (USP)
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D04431
DBLINKS     PubChem: 47206301
///
